Schlieren, Switzerland

Welcome Aboard, Dr. Rothmaier! Leading the Charge in Antibacterial Innovation 

Anne Graham, COO and Co-Founder Our team at Polaroid Therapeutics is rapidly growing, and we're thrilled to announce Dr. Markus Rothmaier's appointment as our inaugural Head of Research and Development (R&D).   Markus brings over two…

Anne Graham, COO and Co-Founder

Our team at Polaroid Therapeutics is rapidly growing, and we’re thrilled to announce Dr. Markus Rothmaier’s appointment as our inaugural Head of Research and Development (R&D).  

Markus brings over two decades of experience in medical device R&D leadership, and his expertise will be instrumental in propelling our revolutionary antibacterial technologies forward. 

In his role, Markus will steer our new product development. His extensive experience positions him perfectly to aid us in creating superior products which help to tackle one of the most pressing global health challenges: antimicrobial resistance (AMR).  

“Markus Rothmaier is joining Polaroid Therapeutics at a critical and exciting time. We welcome his world-class experience and proven track record of driving the development of novel therapies and bringing transformative treatments to patients in need.” – Ran ​​Frenkel, CEO and co-founder.

A World-Class Team for World-Class Solutions 

At Polaroid Therapeutics, we’re developing antimicrobial therapies based on proprietary technology, with the goal to prevent and inhibit infections in multiple indications, such as acute and chronic wounds. In doing so, we’ll address high unmet medical needs and improve patient outcomes. 

Markus’s appointment is a significant milestone for Polaroid Therapeutics, marking a new era of innovation and growth. His leadership and strategic vision underscore our commitment to building a world-class team dedicated to developing ground-breaking therapies.  

 

Joining the Fight 

Our mission is to bring to life the best of Polaroid’s vision of creating a more human and meaningful world through cutting-edge technology and research: a vision Markus shares with great enthusiasm. 

“I am honoured to join Polaroid Therapeutics at such a pivotal moment in the company’s start-up journey. The opportunity to contribute to the pipeline of cutting-edge antibacterial technologies that have the potential to address urgent global health challenges is incredibly inspiring.” – Markus Rothmaier 

Markus will also seek to establish a network of industry-leading partners to translate innovative science into tangible solutions that make a meaningful impact. So, if you think you can contribute to our mission, don’t hesitate to reach out to our team.